DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
- PMID: 40939586
- DOI: 10.1016/j.ymthe.2025.08.041
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Erratum for
-
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.Mol Ther. 2023 Feb 1;31(2):471-486. doi: 10.1016/j.ymthe.2022.08.005. Epub 2022 Aug 13. Mol Ther. 2023. PMID: 35965411 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources